Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- metrizamide
- milnacipran
Interactions between your drugs
metrizamide milnacipran
Applies to: metrizamide, milnacipran
Before you undergo any imaging procedure where metrizamide may be injected directly into the spine, let your doctor know if you are currently being treated with milnacipran. Injection of metrizamide into the spine can sometimes cause seizures, and the risk may be increased if you are also using other medications that can cause seizures such as milnacipran. You may be more susceptible if you are elderly, undergoing alcohol or drug withdrawal, have a history of seizures, or have a condition affecting the central nervous system such as a brain tumor or head trauma. Your doctor may want to withhold milnacipran for a certain length of time before and after the procedure, or you may need to be monitored more closely during the procedure. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
milnacipran food
Applies to: milnacipran
Milnacipran may cause liver damage, and taking it with alcohol may increase that risk. You should avoid or limit the use of alcohol while being treated with milnacipran. Call your doctor immediately if you have fever, chills, joint pain or swelling, excessive tiredness or weakness, unusual bleeding or bruising, skin rash or itching, loss of appetite, nausea, vomiting, dark colored urine, or yellowing of the skin or the whites of your eyes, as these may be symptoms of liver damage. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Isovue-M-200
Isovue-M-200 is used for endoscopy or radiology premedication
Isovue-M-300
Isovue-M-300 is used for endoscopy or radiology premedication
Omnipaque 12
Omnipaque 12 is used for angiocardiography, aortography, body imaging, cerebral arteriography ...
Omnipaque 140
Omnipaque 140 is used for angiocardiography, aortography, arthrography, body imaging, cerebral ...
Omnipaque 180
Omnipaque 180 is used for angiocardiography, aortography, arthrography, body imaging, cerebral ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.